Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.07.03.661735

Peripheral T Helper Cells Dominate the Synovial CD4⁺ T Cell Compartment in Systemic Juvenile Idiopathic Arthritis and Are Shaped by IL-1β and IL-18

Abstract

ObjectivesSystemic juvenile idiopathic arthritis (sJIA Stills disease) is primarily driven by systemic autoinflammation but can progress to chronic arthritis, implicating dysregulated adaptive immunity. However, the molecular mechanisms within inflamed joints that link innate and adaptive immune activation remain poorly defined. This study aimed to define the transcriptional and clonal landscape of synovial CD4+ T cells in sJIA and to identify inflammatory signals driving their differentiation. MethodsSynovial fluid CD4+ T cells from patients with sJIA and oligo/polyarticular JIA (o/p-JIA) were analyzed using flow cytometry, scRNA and TCR sequencing. Cytokine secretion and B helper function were assessed in vitro. The effects of IL-1{beta} and IL-18 on T cell differentiation were evaluated using bulk RNA sequencing and multiplex ELISA. ResultssJIA joints harbored a dominant population of clonally expanded CD4+ T cells with a peripheral T helper (Tph) cell state, marked by IL-21 and CXCL13 expression and robust B cell help. scRNA-seq revealed a heterogeneous CD4+ T cell landscape, with transcriptional convergence of Tph and regulatory (Treg) programs particularly in sJIA. A subset of these cells exhibited molecular features consistent with differentiation from Tph precursors. In vitro, IL-1{beta} and IL-18 promoted Tph differentiation, aligning with the transcriptional profiles of expanded effector Tph cells observed in sJIA joints. ConclusionThese findings identify Tph cell-driven adaptive immunity as a key feature of chronic arthritis in sJIA and link IL-1{beta} and IL-18 to Tph cell induction. This challenges the classical autoinflammatory paradigm and suggests that early cytokine-targeted therapy may modulate T cell fate and disease course.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dirks, J., Fischer, J., Harrer, L., Bracaglia, C., Prencipe, G., Pardeo, M., Magni-Manzoni, S., Caiello, I., Holl Wieden, A., Girschick, H., Kessel, C., Morbach, H.. 2025-07-05. Peripheral T Helper Cells Dominate the Synovial CD4⁺ T Cell Compartment in Systemic Juvenile Idiopathic Arthritis and Are Shaped by IL-1β and IL-18. https://doi.org/10.1101/2025.07.03.661735

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗

The antagonism of sex chromosomes and sex hormones dictates outcomes in Th17 cell-mediated central nervous system autoimmunity.

Biological sex traits are shaped by the combined effects of both sex hormones and chromosomes. How these factors interact in sex-related autoimmune diseases, such as multiple sclerosis (MS), has been a subject of intense recent interest. Here, using the Four Core Genotype (FCG) mouse model, in which these two variables can be disentangled, we describe an antagonism between sex hormones and chromosomes that potently influences outcomes in T helper 17 (Th17)-driven progressive central nervous system (CNS) autoimmunity. Male gonadal hormones dampen disease severity, irrespective of sex chromosome complement, by promoting a Wnt/{beta}-catenin signaling program associated with a homeostatic, non-pathogenic Th17 phenotype. By contrast, XY chromosomal complement exacerbates Th17 pathogenicity in a recipient sex-dependent manner; we identify the X-linked molecule SUV39H1 as an inhibitor of inflammatory Th17 cell function. Unexpectedly, we found that hormonally and chromosomally female FCG Th17 cells induced far more severe disease than WT female counterparts despite being genetically identical, pointing to a parental imprinting effect in dictating Th17 cell pathogenicity. These latter investigations uncovered Runx2, a transcription factor previously linked to developmental programs, as a novel negative regulator of the pathogenicity of Th17 cells. Together, our findings establish biological sex as a multilayered regulator of Th17 pathogenicity, revealing distinct and sometimes opposing contributions of hormones, chromosomes, and parental inheritance.

immunology↗